GK/Slc |
blood total cholesterol level |
vehicle control condition (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
blood cholesterol amount |
male |
105 days
| 0 |
77.8 |
mg/dl |
5.2 |
|
blood cholesterol analysis |
0.0 |
0 |
n=4-6 |
102892 |
2781 |
Jcl:WI |
blood total cholesterol level |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
60.62 |
mg/dl |
3.0 |
8.49 |
blood cholesterol analysis |
0.0 |
0 |
|
103080 |
2785 |
OLETF |
blood total cholesterol level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364 days
| 12 |
168.73 |
mg/dl |
8.88 |
30.76 |
blood cholesterol analysis |
0.0 |
0 |
|
99431 |
2298 |
OLETF |
blood total cholesterol level |
temocapril (3.9 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364 days
| 11 |
78.38 |
mg/dl |
2.7 |
8.96 |
blood cholesterol analysis |
0.0 |
0 |
|
99434 |
2298 |
Slc:W |
blood total cholesterol level |
vehicle control condition (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
blood cholesterol amount |
male |
105 days
| 0 |
67.0 |
mg/dl |
3.5 |
|
blood cholesterol analysis |
0.0 |
0 |
n=4-6 |
102890 |
2781 |
GK/Jcl |
blood total cholesterol level |
Omacor (400 mg/kg/d) (for 56 days) |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
76.83 |
mg/dl |
2.18 |
6.18 |
blood cholesterol analysis |
0.0 |
0 |
|
103082 |
2785 |
SS.ZUC-Leprfa-/-/Slc |
blood total cholesterol level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood cholesterol amount |
male |
91 days
| 7 |
329.25 |
mg/dl |
52.32 |
138.43 |
blood cholesterol analysis |
0.0 |
0 |
|
101839 |
2641 |
SS.ZUC-Leprfa+/+/Slc |
blood total cholesterol level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood cholesterol amount |
male |
91 days
| 10 |
11.83 |
mg/dl |
8.11 |
25.65 |
blood cholesterol analysis |
0.0 |
0 |
|
101838 |
2641 |
GK/Jcl |
blood total cholesterol level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
83.01 |
mg/dl |
0.96 |
2.7 |
blood cholesterol analysis |
0.0 |
0 |
|
103081 |
2785 |
LETO |
blood total cholesterol level |
control condition (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364 days
| 11 |
67.95 |
mg/dl |
1.54 |
5.12 |
blood cholesterol analysis |
0.0 |
0 |
|
99435 |
2298 |
Slc:W |
blood total cholesterol level |
controlled ipragliflozin content diet (0.008 %) (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
blood cholesterol amount |
male |
105 days
| 0 |
58.2 |
mg/dl |
3.0 |
|
blood cholesterol analysis |
0.0 |
0 |
n=4-6 |
102891 |
2781 |
SS.ZUC-Leprfa+/+/Slc |
blood total cholesterol level |
control condition |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood cholesterol amount |
male |
91 days
| 8 |
68.0 |
mg/dl |
2.0 |
5.66 |
blood cholesterol analysis |
0.0 |
0 |
|
101837 |
2641 |
GK/Slc |
blood total cholesterol level |
controlled ipragliflozin content diet (0.008 %) (for 21 days) |
Iuchi H, et al., Sci Rep. 2017 Sep 19;7(1):11906. doi: 10.1038/s41598-017-12106-y. |
blood cholesterol amount |
male |
105 days
| 0 |
78.8 |
mg/dl |
3.8 |
|
blood cholesterol analysis |
0.0 |
0 |
n=4-6 |
102893 |
2781 |
Jcl:WI |
blood total cholesterol level |
standard diet |
Radosinska J, et al., Physiol Res. 2015;64(6):795-806. Epub 2015 Oct 8. |
blood cholesterol amount |
male |
84 days
| 8 |
51.74 |
mg/dl |
2.59 |
7.34 |
blood cholesterol analysis |
0.0 |
0 |
|
103079 |
2785 |
OLETF |
blood total cholesterol level |
olmesartan medoxomil (0.35 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364 days
| 11 |
153.28 |
mg/dl |
7.72 |
25.61 |
blood cholesterol analysis |
0.0 |
0 |
|
99432 |
2298 |
OLETF |
blood total cholesterol level |
olmesartan medoxomil (3.8 mg/kg/d) (for 84 days) |
Koga K, et al., Mol Med. 2002 Oct;8(10):591-9. |
blood cholesterol amount |
male |
364 days
| 12 |
93.44 |
mg/dl |
5.02 |
17.39 |
blood cholesterol analysis |
0.0 |
0 |
|
99433 |
2298 |
SS.ZUC-Leprfa-/-/Slc |
blood total cholesterol level |
everolimus (0.83 mg/kg/d) (for 28 days) |
Uchinaka A, et al., Pharmacol Res Perspect. 2017 Aug;5(4). doi: 10.1002/prp2.331. |
blood cholesterol amount |
male |
91 days
| 12 |
297.67 |
mg/dl |
35.78 |
123.95 |
blood cholesterol analysis |
0.0 |
0 |
|
101840 |
2641 |